BeOne Medicines AG logo

BeOne Medicines AG

ONC | NASDAQ
Chart Builder DCF Calculator
$387.25
+$9.47 (+2.51%)
At close: Nov 5, 2026, 4:00 PM ET
$380.00
-$7.25 (-1.87%)
After-hours: Nov 5, 2026, 5:12 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
286.93M -644.79M -881.71M -2B -1.41B -1.6B
Depreciation & Amortization
141.69M 171.76M 87.68M 66.28M 46.46M 31.79M
Stock-Based Compensation
510.86M 441.62M 367.62M 303.16M 240.71M 183.48M
Other Working Capital
370.16M 142.28M -62.77M -110.68M 438M 103.29M
Other Non-Cash Items
-12.77M 21.96M -361.19M 3.31M -13.11M -20.99M
Deferred Income Tax
9.47M 25.98M 689K 2.06M -41.09M -27.81M
Change in Working Capital
191.4M -157.17M -370.54M 132.39M -118.35M 150.58M
Operating Cash Flow
1.13B -140.63M -1.16B -1.5B -1.3B -1.28B
Capital Expenditures
-185.84M -529.14M -596.26M -469.1M -314.85M -229.03M
Cash Acquisitions
n/a n/a n/a -1.4B 51.91M 109.5M
Purchase of Investments
-11.83M -19.01M -14.9M -17.4M -2.19B -5.69B
Sales Maturities Of Investments
3.45M 2.66M 673.24M 1.56B 3.15B 2.75B
Other Investing Acitivies
-81.93M -39.34M -36.44M 1.4B -51.91M -109.5M
Investing Cash Flow
-276.16M -548.35M 60M 1.08B 640.66M -3.17B
Debt Repayment
889.71M 145.08M 360.77M -65.94M 101.53M 289.6M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-27.06M 48.37M 55.71M 46.96M 92.76M 681.21M
Financial Cash Flow
1.06B 193.45M 416.48M -18.97M 3.64B 5.2B
Net Cash Flow
1.97B -547.24M -689.05M -507.85M 2.99B 769.23M
Free Cash Flow
941.74M -669.77M -1.75B -1.97B -1.61B -1.51B
Adj. Free Cash Flow
430.88M -1.11B -2.12B -2.27B -1.85B -1.7B
Maintenance CapEx
n/a n/a n/a -301.12M n/a -229.03M
Growth CapEx
-185.84M -529.14M -596.26M -167.98M -314.85M n/a
Owner Earnings
1.13B -140.63M -1.16B -1.8B -1.3B -1.51B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.